|
New EXTEND Analyses Evaluate Efficacy Of Single Agent PIXUVRI® In 3rd And …
Daily Markets Compared to physicians’ choice of other agents given as monotherapy, single agent PIXUVRI resulted in 30 percent of patients who had previously received rituximab achieving a complete or unconfirmed durable complete response lasting on average 9.5 … |
|
New EXTEND Analyses Evaluate Efficacy of Single Agent PIXUVRI(R) in 3rd …
Wall Street Journal (press release) Compared to physicians’ choice of other agents given as monotherapy, single agent PIXUVRI resulted in 30 percent of patients who had previously received rituximab achieving a complete or unconfirmed durable complete response lasting on average 9.5 … |
|
New EXTEND Analyses Evaluate Efficacy of Single Agent PIXUVRI in 3rd and …
MarketWatch (press release) Compared to physicians’ choice of other agents given as monotherapy, single agent PIXUVRI resulted in 30 percent of patients who had previously received rituximab achieving a complete or unconfirmed durable complete response lasting on average 9.5 … |
|
New EXTEND Analyses Evaluate Efficacy of Single Agent PIXUVRI® in 3rd and …
PR Newswire (press release) Compared to physicians’ choice of other agents given as monotherapy, single agent PIXUVRI resulted in 30 percent of patients who had previously received rituximab achieving a complete or unconfirmed durable complete response lasting on average 9.5 … |
|
Hunter-killer antibodies chasing down cancer
TechRadar UK This Week in Science promises to be yet another corker. From nuclear bomb blasts unveiling the hidden workings of our brains, to the prospect of volcanoes producing bountiful clean energy to power our world, it’s all been rocking. But, arguably the … |
|
What’s the beef? Bovine antibodies X-rayed
spectroscopyNOW.com US researchers have used X-ray diffraction to study several novel bovine antibodies that might one day lead to new types of agent against infectious pathogens. Cattle have been with us for millennia providing us with nutrition, clothing, shoes and most … |
|
Zusetzen von Obinutuzumab (GA101) oder Rituximab zu Chlorambucil …
FinanzNachrichten.de (Pressemitteilung) Zugehörigkeit: Deutsche CLL-Studiengruppe, Köln, Deutschland Thema: Zusetzen von Obinutuzumab (GA101) oder Rituximab zu Chlorambucil verbessert Aussichten für ältere Patienten mit chronischer lymphatischer Leukämie (CLL) und Komorbiditäten … |
Research and Markets: Triple Analysis: Prostate Cancer, Cancer Vaccines and …Wall Street Journal (press release)This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/targ…
Research and Markets: Triple Analysis: Prostate Cancer, Cancer Vaccines and …Business Wire (press release)This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/eff…
Addition of obinutuzumab (GA101) or rituximab to chlorambucil Improves …SYS-CON Media (press release)Is Your Business 100% Ready for the New Era of Cloud Computing and Big Data? The Only Enterprise IT Event in 2013 Covering the Entire Scope of both C…